Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6 Pt 1
pubmed:dateCreated
1999-1-19
pubmed:abstractText
Oral immunotherapy with a peptide for allergic immune responses is theoretically a promising therapy but has not been established yet.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0091-6749
pubmed:author
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
961-7
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:9847437-Administration, Intranasal, pubmed-meshheading:9847437-Administration, Oral, pubmed-meshheading:9847437-Allergens, pubmed-meshheading:9847437-Animals, pubmed-meshheading:9847437-Cells, Cultured, pubmed-meshheading:9847437-Cholera Toxin, pubmed-meshheading:9847437-Epitopes, T-Lymphocyte, pubmed-meshheading:9847437-Female, pubmed-meshheading:9847437-Immune Tolerance, pubmed-meshheading:9847437-Immunodominant Epitopes, pubmed-meshheading:9847437-Immunoglobulin E, pubmed-meshheading:9847437-Immunoglobulin G, pubmed-meshheading:9847437-Lymph Nodes, pubmed-meshheading:9847437-Lymphocyte Activation, pubmed-meshheading:9847437-Mice, pubmed-meshheading:9847437-Mice, Inbred BALB C, pubmed-meshheading:9847437-Nasal Mucosa, pubmed-meshheading:9847437-Peptides, pubmed-meshheading:9847437-Plant Proteins, pubmed-meshheading:9847437-Pollen, pubmed-meshheading:9847437-Th1 Cells, pubmed-meshheading:9847437-Th2 Cells, pubmed-meshheading:9847437-Trees
pubmed:year
1998
pubmed:articleTitle
Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cry j 2-primed mice.
pubmed:affiliation
Sankyo Co, Ltd, Tokyo.
pubmed:publicationType
Journal Article